Universal Screening of Gastrointestinal Malignancies for Mismatch Repair Deficiency at Stanford

BACKGROUND: In light of recent Food and Drug Administration (FDA) approval of immune checkpoint inhibitors for mismatch repair deficient (dMMR) malignancies, identifying patients with dMMR malignancies has become increasingly important. Although screening for dMMR in colorectal cancer (CRC) is recom...

Descripción completa

Detalles Bibliográficos
Autores principales: Abrha, Aser, Shukla, Navika D, Hodan, Rachel, Longacre, Teri, Raghavan, Shyam, Pritchard, Colin C, Fisher, George, Ford, James, Haraldsdottir, Sigurdis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667994/
https://www.ncbi.nlm.nih.gov/pubmed/33225206
http://dx.doi.org/10.1093/jncics/pkaa054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667994/
https://www.ncbi.nlm.nih.gov/pubmed/33225206
http://dx.doi.org/10.1093/jncics/pkaa054

Ejemplares similares